The Chance to Find Cancer Early

Your Providence provider is now offering the Galleri™ multi-cancer early detection test, which can detect more than 50 types of cancer from a simple blood test.

Request the Galleri test

The Chance to Find Cancer Early

Your Providence provider is now offering the GalleriTM multi-cancer early detection test, which can detect more than 50 types of cancer from a simple blood test.

Request the Galleri test

Finding Cancer Early is Important

Thinking about the possibility of having cancer can be overwhelming, but taking steps to find cancer early can help you feel more in control. Often, the earlier that cancer can be found, the higher the chance of better outcomes.3

of cancer deaths in people ages 50-79 are caused by cancers not commonly screened for.4,5,6

In fact, when cancers are diagnosed early before they have had a chance to spread, the overall 5-year survival rate is  4x higher  than when diagnosed in later stages.3,7

Finding Cancer Early is Important

Thinking about the possibility of having cancer can be overwhelming, but taking steps to find cancer early can help you feel more in control. Often, the earlier that cancer can be found, the higher the chance of better outcomes.3

of cancer deaths in people ages 50-79 are caused by cancers not commonly screened for.4,5,6

In fact, when cancers are diagnosed early before they have had a chance to spread, the overall 5-year survival rate is  4x higher  than when diagnosed in later stages.3,7

*Video embedded from YouTube

The Galleri test, GRAIL’s muti-cancer early detection test, detects more than 50 types of cancer, many of which are not commonly screened for today, including pancreatic cancer. All that’s required is a simple blood draw.1,2,8

Would you like to be notified when eligibility requirements change?



The Benefits of Multi-Cancer Detection

Early cancer detection

Detects many cancers not commonly screened for today, to allow for earlier treatment.1,8

Testing with ease

Completed with a simple blood draw.

Actionable results

If a cancer signal is found, the results can point to where in the body the cancer is coming from with high accuracy.

The Galleri test is intended to be used in addition to, and not replace, other cancer screening tests your health care provider recommends. The Galleri test does not detect all cancers nor does it measure your genetic risk of developing cancer in the future.

The Benefits of Multi-Cancer Detection

Early cancer detection

Detects many cancers not commonly screened for today, to allow for earlier treatment.1,8

Testing with ease

Completed with a simple blood draw.

Actionable results

If a cancer signal is found, the results can point to where in the body the cancer is coming from with high accuracy.

The Galleri test is intended to be used in addition to, and not replace, other cancer screening tests your health care provider recommends. The Galleri test does not detect all cancers nor does it measure your genetic risk of developing cancer in the future.

Am I Eligible for the Galleri test?

The current criteria are not meant to represent a comprehensive list of all cancer risk factors but are a starting point to offer the Galleri test.

Between the ages of 40-49?

Certain risk factors may put you at an elevated risk for developing cancer. The Galleri test may be right for you if you meet one or more of the following criteria:

  • You are a smoker or have quit smoking in the last 10 years
  • You have a first degree relative (parent, child and/or full sibling) who has had cancer
  • You have tested positive for HIV
  • You have received an organ transplant

50 OR OLDER?

Our risk of cancer increases as we age and the risk of developing cancer starts to increase significantly over the age of 50, so all individuals 50 or older are eligible for the Galleri Test.

CURRENTLY, THE FOLLOWING INDIVIDUALS ARE NOT ELIGIBLE FOR THE GALLERI TEST:

  • You have been diagnosed or treated for cancer within the past three years
    • This excludes basal or squamous cell carcinomas of the skin
    • This also excludes hormonal therapy (e.g., Tamoxifen, Arimidex, Aromasin) for breast cancer; you need to be 3 years past surgery, chemotherapy and/or radiotherapy but can still be taking hormonal therapy
  • You are 39 years of age or younger
  • You are currently pregnant
  • You live outside of the United States

You will be charged $949 for the test and associated services once your sample has been received by GRAIL. Price includes the Galleri test and blood draw services at partner labs.

Am I Eligible for the Galleri test?

The current criteria are not meant to represent a comprehensive list of all cancer risk factors but are a starting point to offer the Galleri test.

BETWEEN THE AGES OF 40-49?

Certain risk factors may put you at an elevated risk for developing cancer. The Galleri test may be right for you if you meet one or more of the following criteria:

  • You are a smoker or have quit smoking in the last 10 years
  • You have a first degree relative (parent, child and/or full sibling) who has had cancer
  • You have tested positive for HIV
  • You have received an organ transplant

50 OR OLDER?

Our risk of cancer increases as we age and the risk of developing cancer starts to increase significantly over the age of 50, so all individuals 50 or older are eligible for the Galleri Test.

CURRENTLY, THE FOLLOWING INDIVIDUALS ARE NOT ELIGIBLE FOR THE GALLERI TEST:

  • You have been diagnosed or treated for cancer within the past three years
    • This excludes basal or squamous cell carcinomas of the skin
    • This also excludes hormonal therapy (e.g., Tamoxifen, Arimidex, Aromasin) for breast cancer; you need to be 3 years past surgery, chemotherapy and/or radiotherapy but can still be taking hormonal therapy
  • You are 39 years of age or younger
  • You are currently pregnant
  • You live outside of the United States

You will be charged $949 for the test and associated services once your sample has been received by GRAIL. Price includes the Galleri test and blood draw services at partner labs.



Test Process

Follow the process with just three steps.

Request the
Galleri test

Learn more

Complete your
blood draw

Learn more

Receive your test result
from your Providence provider

Learn more

Test Process

Follow the process with just three steps.

Request the Galleri test

Learn more

Complete your blood draw

Learn more

Receive your test result
from your Providence provider

Learn more

Get Started

Request the test from your provider

If your provider is already trained to order Galleri,
you can contact them directly to request the test.

Get Started

Request the test from your provider

If your provider is already trained to order Galleri, you can contact them directly to request the test.

Get a blood draw

If your test has been authorized by your provider, a Galleri collection kit will be mailed directly to you with directions on how to locate a partner laboratory to have your blood drawn. Please do not open the kit. You must take the kit to the lab unopened.

Locate a lab near you

Make sure you have the following in hand for your blood draw:

Your Galleri collection kit

Will be shipped directly to you

Your completed and printed
Test Requisition Form

GRAIL will email this to you after your test has been authorized by your provider

If you are a current patient who has questions about scheduling a blood draw, please find more information here or contact GRAIL Customer Service at 833-694-2553 or customerservice@grail.com.

Get a blood draw

If your test has been authorized by your provider, a Galleri collection kit will be mailed directly to you with directions on how to locate a partner laboratory to have your blood drawn. Please do not open the kit. You must take the kit to the lab unopened.

Locate a lab near you

Make sure you have the following in hand for your blood draw:

Your Galleri collection kit

Will be shipped directly to you

Your completed and printed Test Requisition Form

GRAIL will email this to you after your test has been authorized by your provider

If you are a current patient who has questions about scheduling a blood draw, please find more information here or contact GRAIL Customer Service at 833-694-2553 or customerservice@grail.com.

Receive your results

Your results will be available approximately two weeks after your sample arrives at the GRAIL laboratory. At that time, your provider will contact you to review your results.

There are two possible results from the Galleri test:

Cancer Signal NOT Detected

This means that no cancer signal was found. However not all cancer types can be detected by the Galleri test, and the Galleri test may not detect all early stage cancers.

Cancer Signal Detected

This means that there is a suspicion of cancer. The Galleri test can point to where in the body (e.g., colon, head and neck) the cancer signal is coming from with high accuracy to help your health care provider guide next steps. Sometimes the test may indicate two locations in the body where the cancer signal may be coming from which may require separate follow-up evaluations.

Next steps:

Continue with all routine screening tests that your healthcare provider recommends. Missing routine cancer screenings or ignoring symptoms could lead to a delayed diagnosis of cancer. If you’re interested in repeating the Galleri test in one year, please contact your provider.

Next steps:

The Galleri test does not diagnose cancer. Additional tests are needed to determine if cancer is present, which may include imaging or blood work.

The test does not measure your genetic risk of developing cancer in the future. With the Galleri multi-cancer early detection test, annual screening provides the opportunity to detect more cancers early. Your health care provider can help you determine when to take the Galleri test again based on your risk factors.

False-positive and false-negative test results can occur. The Galleri test has a low false-positive rate of 0.5% (detecting a cancer signal when no cancer is present).1

Receive your results

Your results will be available approximately two weeks after your sample arrives at the GRAIL laboratory. At that time, your provider will contact you to review your results.

There are two possible results from the Galleri test:

Cancer Signal NOT Detected

This means that no cancer signal was found. However not all cancer types can be detected by the Galleri test, and the Galleri test may not detect all early stage cancers.

Next steps:

Continue with all routine screening tests that your healthcare provider recommends. Missing routine cancer screenings or ignoring symptoms could lead to a delayed diagnosis of cancer. If you’re interested in repeating the Galleri test in one year, please contact your provider.

Cancer Signal Detected

This means that there is a suspicion of cancer. The Galleri test can point to where in the body (e.g., colon, head and neck) the cancer signal is coming from with high accuracy to help your health care provider guide next steps. Sometimes the test may indicate two locations in the body where the cancer signal may be coming from which may require separate follow-up evaluations.

Next steps:

The Galleri test does not diagnose cancer. Additional tests are needed to determine if cancer is present, which may include imaging or blood work.

The test does not measure your genetic risk of developing cancer in the future. With the Galleri multi-cancer early detection test, annual screening provides the opportunity to detect more cancers early. Your health care provider can help you determine when to take the Galleri test again based on your risk factors.

False-positive and false-negative test results can occur. The Galleri test has a low false-positive rate of 0.5% (detecting a cancer signal when no cancer is present).1

Breakthrough Test Performance

sensitivity*

This means that the Galleri test reported a “Cancer Signal Detected” result in approximately 52 individuals out of 100 who actually had cancer.1

specificity

This means that the Galleri test reported a “Cancer Signal Not Detected” result in approximately 99 individuals out of 100 who do not actually have cancer.1

false positive rate

This means that the Galleri test reported a “Cancer Signal Detected” result 1 in every 200 tests run in individuals who did NOT actually have cancer.1

Cancer Signal Origin Accuracy

This means when a cancer signal was detected in an individual who actually had cancer, the Cancer Signal Origin was correctly predicted in 89 of 100 times.1

*Sensitivity value is for all cancers and participants of all ages included in the CCGA3 subset.

Breakthrough Test Performance

sensitivity*

This means that the Galleri test reported a “Cancer Signal Detected” result in approximately 52 individuals out of 100 who actually had cancer.1

sensitivity*

This means that the Galleri test reported a “Cancer Signal Detected” result in approximately 52 individuals out of 100 who actually had cancer.1

specificity

This means that the Galleri test reported a “Cancer Signal Not Detected” result in approximately 99 individuals out of 100 who do not actually have cancer.1

false positive rate

This means that the Galleri test reported a “Cancer Signal Detected” result 1 in every 200 tests run in individuals who did NOT actually have cancer.1

Cancer Signal Origin Accuracy

This means when a cancer signal was detected in an individual who actually had cancer, the Cancer Signal Origin was correctly predicted in 89 of 100 times.1

*Sensitivity value is for all cancers and participants of all ages included in the CCGA3 subset.

Have questions?

Contact us

Have questions?

Contact us

Frequently Asked Questions

What is the Galleri test?

The Galleri test is a multi-cancer early detection test that detects more than 50 types of cancer, many of which are not commonly screened for today, through a simple blood draw. The Galleri test does not diagnose cancer and not all cancers may be detected in the blood.

What cancers does the Galleri test detect?

In a large-scale clinical evaluation sub-study of more than 4,000 people, the Galleri test detected more than 50 cancer types across all stages. The test identified ~17% of individuals with stage I cancer, 40% with stage II cancer, 77% of individuals with stage III cancer and 90% of stage IV cancers.

How can the Galleri test detect cancer in the blood?

The Galleri test looks for signals present in the blood that may be associated with cancer at the time of your blood draw. If a cancer signal is detected, the results can accurately point to where in the body the cancer signal is coming from to help your healthcare provider guide next steps.

Why is the Galleri test recommended to be used along with other cancer screening tests?

The Galleri test screens for more than 50 cancers; however, not all cancers may be detected in the blood. Recommended routine cancer screening tests, such as a colonoscopy or mammogram are commonly used and have been shown to reduce cancer deaths. Galleri is intended to be used in addition to, not to replace, these tests and can help maximize the benefits of early cancer detection. Missing recommended screening or ignoring symptoms could lead to a delayed diagnosis of cancer. Ask your healthcare provider about which cancer screening tests are right for you.

Who is eligible for the Galleri test?

The Galleri test is recommended for adults with an elevated risk for developing cancer, such as individuals 50 years of age or older.

If you’re at least 40 years old and at an elevated risk for developing cancer, you may also be eligible for the Galleri test based on the following criteria:

LIFESTYLE FACTORS

You are a current smoker or have quit smoking within the last 10 years.

FAMILY CANCER HISTORY
You have a first degree relative (parent, child, and/or a full brother or sister), who has had cancer

HISTORY OF IMMUNOSUPPRESSION
You have history of HIV infection
You are an organ transplant recipient

At this time the Galleri test might not be right for you if:
You have a personal history of cancer (this does NOT include a basal or squamous cell carcinoma of the skin)
You are 39 years of age or younger
You live outside of the United States

Is the test available outside of the United States?

The Galleri test is not yet commercially available outside of the United States or in US territories.

I am not eligible based on the age requirement for the Galleri test, can I still request the test?

The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those aged 50 or older.

What is the false positive rate of the Galleri test?

The Galleri test has a low false-positive rate of 0.5% (detecting a cancer signal when no cancer is present). This means that in approximately 200 people tested, only 1 person would be expected to receive a false positive result.

What data supports the Galleri test?

The Galleri test development was supported by what is believed to be the largest clinical study program in genomic medicine, with over 20,000 participants at more than 140 clinical study sites, including the Mayo Clinic, Dana-Farber Cancer Institute, Cleveland Clinic, Sutter Health, Oregon Health & Science University, Intermountain Healthcare, and U.S. Oncology Research.

Who are the Partners Involved?

  • Providence Health System is offering the Galleri test from GRAIL. You should contact your Providence provider to discuss and order the test.
  • GRAIL is the manufacturer of the Galleri test.
  • Genome Medical is a Providence Health System partner who is assisting Providence patients with information related to the Galleri test offering at Providence Health System.

How quickly will I receive my results?

It takes about 2 weeks after your blood draw to receive your test results.

At that time, your healthcare provider will contact you to review your test results and discuss the next steps.

What does it mean if I receive a “Cancer Signal Not Detected” result?

This means that no cancer signal was found. However, not all cancers can be detected by the Galleri test, and not all cancers may be detected in the blood. Continue with all routine screening tests that your healthcare provider recommends. Missing routine screenings or ignoring symptoms can lead to a delayed diagnosis of cancer.

What does it mean if I receive a “Cancer Signal Detected” result?

This means that there is a suspicion of cancer, but not a diagnosis of cancer. Your provider will share this result with you and what it may mean.

The Galleri test can point to where in the body the cancer is coming from with high accuracy to help your primary healthcare provider guide next steps. Your primary healthcare provider should order appropriate follow-up testing to confirm if cancer is present.

Why are additional tests needed when the Galleri test detects a cancer signal?

Galleri is a screening test that detects cancer signals in blood. When a signal is detected, the Galleri test also indicates where in the body the signal is coming from with high accuracy.

The Galleri test is not a diagnostic test to confirm cancer status. Additional tests ordered by your primary healthcare provider are needed to confirm if cancer is present which may include blood work or imaging.

Will the additional tests be covered by insurance?

Insurance coverage for bloodwork and imaging studies is generally covered by insurers when there is an indication or reason to order them. Since the Galleri test is a new screening test, it is possible that your insurance may not cover some of the additional tests.

I submitted my test request. What happens next?

If your Providence provider approves your test request, they will order the test for you.

Once your test order is submitted, GRAIL will email you your completed test requisition form with directions on where to go for your blood draw. At that time, you will be shipped a Galleri specimen collection kit that you will bring to your blood draw appointment.

Once you receive your collection kit in the mail, you can schedule a blood draw appointment at one of GRAIL’s partner laboratories. Please do not open your collection kit – this should remain unopened when you take it to the lab.

Where can I get my blood drawn for the Galleri test?

If your Galleri test request is approved, you can schedule a blood draw appointment with one of GRAIL’s partner laboratories at no additional cost to you.

Please wait to schedule your blood draw appointment until you’ve received your collection kit in the mail. Please do not open your collection kit – this should remain unopened when you take it to the lab.

How do I return the Galleri kit after my blood draw?

The trained practitioner who draws your blood will pack and ship your sample back to the GRAIL laboratory for processing.

Do I need to fast prior to the blood draw?

No preparation or fasting is required.

Some lab technicians may ask if you have fasted, but rest assured this is not required for the Galleri test.

How much blood is needed for the Galleri test?

Approximately 1.5 tablespoons (or about 20 mL) of blood in two tubes typically from a vein in your arm.

How much does the Galleri test cost?

If ordered by a Providence provider, you will be charged a rate of $949 for the test and associated services once your sample has been received by GRAIL. In the near future, this rate will be discounted to $819. This price includes the Galleri test and blood draw services at partner labs. You may be able to use pre-tax dollars in your flexible spending account (FSA) or health savings account (HSA) to pay for the Galleri test. Check with your FSA/HSA account administrator or insurance company to determine eligibility.

Is the Galleri test covered by insurance?

Currently, the Galleri test is not covered by insurance. The Galleri test is new to the market and represents a significant innovation to cancer screening. GRAIL is actively pursuing coverage from various sources; however, this process takes time.

Can I use my HSA/FSA to pay for the Galleri test?

You may be able to use pre-tax dollars in your flexible spending account (FSA) or health savings account (HSA) to pay for the Galleri test. Check with your FSA/HSA account administrator or insurance company to determine eligibility.

How do I pay my Galleri bill?

You will receive an email with instructions to pay your bill once your collection kit is received by GRAIL. You can also pay your bill here or by calling 855-775-3613 with information provided on your statement. You may also send a check payment to GRAIL, Inc. at the following address: GRAIL, Inc. Dept LA 25195 Pasadena, CA 91185-5195 In the memo line on the check include your billing statement number and detach the bottom of your billing statement and send it along with your payment.

Frequently Asked Questions

What is the Galleri test?

The Galleri test is a multi-cancer early detection test that detects more than 50 types of cancer, many of which are not commonly screened for today, through a simple blood draw. The Galleri test does not diagnose cancer and not all cancers may be detected in the blood.

What cancers does the Galleri test detect?

In a large-scale clinical evaluation sub-study of more than 4,000 people, the Galleri test detected more than 50 cancer types across all stages. The test identified ~17% of individuals with stage I cancer, 40% with stage II cancer, 77% of individuals with stage III cancer and 90% of stage IV cancers.

How can the Galleri test detect cancer in the blood?

The Galleri test looks for signals present in the blood that may be associated with cancer at the time of your blood draw. If a cancer signal is detected, the results can accurately point to where in the body the cancer signal is coming from to help your healthcare provider guide next steps.

Why is the Galleri test recommended to be used along with other cancer screening tests?

The Galleri test screens for more than 50 cancers; however, not all cancers may be detected in the blood. Recommended routine cancer screening tests, such as a colonoscopy or mammogram are commonly used and have been shown to reduce cancer deaths. Galleri is intended to be used in addition to, not to replace, these tests and can help maximize the benefits of early cancer detection. Missing recommended screening or ignoring symptoms could lead to a delayed diagnosis of cancer. Ask your healthcare provider about which cancer screening tests are right for you.

Who is eligible for the Galleri test?

The Galleri test is recommended for adults with an elevated risk for developing cancer, such as individuals 50 years of age or older.

If you’re at least 40 years old and at an elevated risk for developing cancer, you may also be eligible for the Galleri test based on the following criteria:

LIFESTYLE FACTORS

You are a current smoker or have quit smoking within the last 10 years.

FAMILY CANCER HISTORY
You have a first degree relative (parent, child, and/or a full brother or sister), who has had cancer

HISTORY OF IMMUNOSUPPRESSION
You have history of HIV infection
You are an organ transplant recipient

At this time the Galleri test might not be right for you if:
You have a personal history of cancer (this does NOT include a basal or squamous cell carcinoma of the skin)
You are 39 years of age or younger
You live outside of the United States

Is the test available outside of the United States?

The Galleri test is not yet commercially available outside of the United States or in US territories.

I am not eligible based on the age requirement for the Galleri test, can I still request the test?

The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those aged 50 or older.

What is the false positive rate of the Galleri test?

The Galleri test has a low false-positive rate of 0.5% (detecting a cancer signal when no cancer is present). This means that in approximately 200 people tested, only 1 person would be expected to receive a false positive result.

What data supports the Galleri test?

The Galleri test development was supported by what is believed to be the largest clinical study program in genomic medicine, with over 20,000 participants at more than 140 clinical study sites, including the Mayo Clinic, Dana-Farber Cancer Institute, Cleveland Clinic, Sutter Health, Oregon Health & Science University, Intermountain Healthcare, and U.S. Oncology Research.

Who are the Partners Involved?

  • Providence Health System is offering the Galleri test from GRAIL. You should contact your Providence provider to discuss and order the test.
  • GRAIL is the manufacturer of the Galleri test.
  • Genome Medical is a Providence Health System partner who is assisting Providence patients with information related to the Galleri test offering at Providence Health System.

How quickly will I receive my results?

It takes about 2 weeks after your blood draw to receive your test results.

At that time, your healthcare provider will contact you to review your test results and discuss the next steps.

What does it mean if I receive a “Cancer Signal Not Detected” result?

This means that no cancer signal was found. However, not all cancers can be detected by the Galleri test, and not all cancers may be detected in the blood. Continue with all routine screening tests that your healthcare provider recommends. Missing routine screenings or ignoring symptoms can lead to a delayed diagnosis of cancer.

What does it mean if I receive a “Cancer Signal Detected” result?

This means that there is a suspicion of cancer, but not a diagnosis of cancer. Your provider will share this result with you and what it may mean.

The Galleri test can point to where in the body the cancer is coming from with high accuracy to help your primary healthcare provider guide next steps. Your primary healthcare provider should order appropriate follow-up testing to confirm if cancer is present.

Why are additional tests needed when the Galleri test detects a cancer signal?

Galleri is a screening test that detects cancer signals in blood. When a signal is detected, the Galleri test also indicates where in the body the signal is coming from with high accuracy.

The Galleri test is not a diagnostic test to confirm cancer status. Additional tests ordered by your primary healthcare provider are needed to confirm if cancer is present which may include blood work or imaging.

Will the additional tests be covered by insurance?

Insurance coverage for bloodwork and imaging studies is generally covered by insurers when there is an indication or reason to order them. Since the Galleri test is a new screening test, it is possible that your insurance may not cover some of the additional tests.

I submitted my test request. What happens next?

If your Providence provider approves your test request, they will order the test for you.

Once your test order is submitted, GRAIL will email you your completed test requisition form with directions on where to go for your blood draw. At that time, you will be shipped a Galleri specimen collection kit that you will bring to your blood draw appointment.

Once you receive your collection kit in the mail, you can schedule a blood draw appointment at one of GRAIL’s partner laboratories. Please do not open your collection kit – this should remain unopened when you take it to the lab.

Where can I get my blood drawn for the Galleri test?

If your Galleri test request is approved, you can schedule a blood draw appointment with one of GRAIL’s partner laboratories at no additional cost to you.

Please wait to schedule your blood draw appointment until you’ve received your collection kit in the mail. Please do not open your collection kit – this should remain unopened when you take it to the lab.

How do I return the Galleri kit after my blood draw?

The trained practitioner who draws your blood will pack and ship your sample back to the GRAIL laboratory for processing.

Do I need to fast prior to the blood draw?

No preparation or fasting is required.

Some lab technicians may ask if you have fasted, but rest assured this is not required for the Galleri test.

How much blood is needed for the Galleri test?

Approximately 1.5 tablespoons (or about 20 mL) of blood in two tubes typically from a vein in your arm.

How much does the Galleri test cost?

If ordered by a Providence provider, you will be charged a rate of $949 for the test and associated services once your sample has been received by GRAIL. In the near future, this rate will be discounted to $819. This price includes the Galleri test and blood draw services at partner labs. You may be able to use pre-tax dollars in your flexible spending account (FSA) or health savings account (HSA) to pay for the Galleri test. Check with your FSA/HSA account administrator or insurance company to determine eligibility.

Is the Galleri test covered by insurance?

Currently, the Galleri test is not covered by insurance. The Galleri test is new to the market and represents a significant innovation to cancer screening. GRAIL is actively pursuing coverage from various sources; however, this process takes time.

Can I use my HSA/FSA to pay for the Galleri test?

You may be able to use pre-tax dollars in your flexible spending account (FSA) or health savings account (HSA) to pay for the Galleri test. Check with your FSA/HSA account administrator or insurance company to determine eligibility.

How do I pay my Galleri bill?

You will receive an email with instructions to pay your bill once your collection kit is received by GRAIL. You can also pay your bill here or by calling 855-775-3613 with information provided on your statement. You may also send a check payment to GRAIL, Inc. at the following address: GRAIL, Inc. Dept LA 25195 Pasadena, CA 91185-5195 In the memo line on the check include your billing statement number and detach the bottom of your billing statement and send it along with your payment.

Important Safety Information

The GalleriTM test is recommended for use in adults with an elevated risk for cancer, such as those aged 50 or older. The Galleri test does not detect all cancers and should be used in addition to routine cancer screening tests recommended by a health care provider. Galleri is intended to detect cancer signals and predict where in the body the cancer signal is located.

Results should be interpreted by a health care provider in the context of medical history, clinical signs and symptoms. A test result of ​“Cancer Signal Not Detected” does not rule out cancer. A test result of ​“Cancer Signal Detected” requires confirmatory diagnostic evaluation by medically established procedures (e.g. imaging) to confirm cancer.

If cancer is not confirmed with further testing, it could mean that cancer is not present or testing was insufficient to detect cancer, including due to the cancer being located in a different part of the body. False-positive (a cancer signal detected when cancer is not present) and false-negative (a cancer signal not detected when cancer is present) test results do occur. Rx only.

Laboratory/Test Information

GRAIL’s clinical laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and accredited by the College of American Pathologists (CAP). The Galleri test was developed, and its performance characteristics were determined by GRAIL. The Galleri test has not been cleared or approved by the Food and Drug Administration. GRAIL’s clinical laboratory is regulated under CLIA to perform high-complexity testing. The Galleri test is intended for clinical purposes.

References and Notes

  1. Klein EA, Richards D, Cohn A, et al. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. Ann Oncol. 2021 Jun 23:S0923-7534(21)02046-9. doi: 10.1016/j.annonc.2021.05.806.
  2. Amin MB, et al. (Eds). American Joint Committee of Cancer (AJCC) Cancer Staging Manual (8th edition).
  3. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence — SEER 18 Regs Research Data. Nov 2018 Sub. Includes persons aged 50 – 79 diagnosed 2006 – 2015. “Early/ Localized” includes invasive localized tumors that have not spread beyond organ of origin. “Late/ Metastasized” includes invasive cancers that have metastasized beyond the organ of origin to other parts of the body.
  4. Modeled detection extrapolated to 2020 US population ages 50 – 79. Screening includes methods with United States Preventive Services Task Force (USPSTF) A, B, or C rating (breast, colon, cervical, prostate, and lung), and assumes screening is available for all prostate, breast, cervical, and colorectal cancer cases and 33% of lung cancer cases (based on estimated proportion of lung cancers that occur in screen-eligible individuals older than 40 years).
  5. Data on file from Surveillance, Epidemiology, and End Results (SEER) 18 Regs Research Data, Nov 2017 Submission. Includes persons aged 50 – 79. Estimated deaths per year in 2020 from American Cancer Society Cancer Facts and Figures 2020. Available at: www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2020/cancer-facts-and-figures-2020.pdf
  6. As of 2021, this is now 68%. Assumes screening is available for all prostate, breast, cervical, and colorectal cancer cases and 43% of lung cancer cases (based on estimated proportion of lung cancers that occur in screen-eligible individuals older than 40 years) Source: Estimated deaths per year in 2021 from American Cancer Society Cancer Facts and Figures 2021. Available at: http://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2021/cancer-facts-and-figures-2021.pdf. Data on file GA-2021-0065
  7. Noone AM, Howlader N, Krapcho M, et al. (eds). SEER Cancer Statistics Review, 1975 – 2015, National Cancer Institute, Bethesda, MD, http://seer.cancer.gov/csr/1975_2015/, based on November 2017 SEER data submission, posted to the SEER website April 2018.
  8. Screening includes methods with United States Preventative Services Task Force (USPSTF) A, B, or C rating (breast, colon, cervical, prostate, and lung).
Important Safety Information

The GalleriTM test is recommended for use in adults with an elevated risk for cancer, such as those aged 50 or older. The Galleri test does not detect all cancers and should be used in addition to routine cancer screening tests recommended by a health care provider. Galleri is intended to detect cancer signals and predict where in the body the cancer signal is located.

Results should be interpreted by a health care provider in the context of medical history, clinical signs and symptoms. A test result of ​“Cancer Signal Not Detected” does not rule out cancer. A test result of ​“Cancer Signal Detected” requires confirmatory diagnostic evaluation by medically established procedures (e.g. imaging) to confirm cancer.

If cancer is not confirmed with further testing, it could mean that cancer is not present or testing was insufficient to detect cancer, including due to the cancer being located in a different part of the body. False-positive (a cancer signal detected when cancer is not present) and false-negative (a cancer signal not detected when cancer is present) test results do occur. Rx only.

Laboratory/Test Information

GRAIL’s clinical laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and accredited by the College of American Pathologists (CAP). The Galleri test was developed, and its performance characteristics were determined by GRAIL. The Galleri test has not been cleared or approved by the Food and Drug Administration. GRAIL’s clinical laboratory is regulated under CLIA to perform high-complexity testing. The Galleri test is intended for clinical purposes.

References and Notes

  1. Klein EA, Richards D, Cohn A, et al. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. Ann Oncol. 2021 Jun 23:S0923-7534(21)02046-9. doi: 10.1016/j.annonc.2021.05.806.
  2. Amin MB, et al. (Eds). American Joint Committee of Cancer (AJCC) Cancer Staging Manual (8th edition).
  3. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence — SEER 18 Regs Research Data. Nov 2018 Sub. Includes persons aged 50 – 79 diagnosed 2006 – 2015. “Early/ Localized” includes invasive localized tumors that have not spread beyond organ of origin. “Late/ Metastasized” includes invasive cancers that have metastasized beyond the organ of origin to other parts of the body.
  4. Modeled detection extrapolated to 2020 US population ages 50 – 79. Screening includes methods with United States Preventive Services Task Force (USPSTF) A, B, or C rating (breast, colon, cervical, prostate, and lung), and assumes screening is available for all prostate, breast, cervical, and colorectal cancer cases and 33% of lung cancer cases (based on estimated proportion of lung cancers that occur in screen-eligible individuals older than 40 years).
  5. Data on file from Surveillance, Epidemiology, and End Results (SEER) 18 Regs Research Data, Nov 2017 Submission. Includes persons aged 50 – 79. Estimated deaths per year in 2020 from American Cancer Society Cancer Facts and Figures 2020. Available at: www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2020/cancer-facts-and-figures-2020.pdf
  6. As of 2021, this is now 68%. Assumes screening is available for all prostate, breast, cervical, and colorectal cancer cases and 43% of lung cancer cases (based on estimated proportion of lung cancers that occur in screen-eligible individuals older than 40 years) Source: Estimated deaths per year in 2021 from American Cancer Society Cancer Facts and Figures 2021. Available at: http://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2021/cancer-facts-and-figures-2021.pdf. Data on file GA-2021-0065
  7. Noone AM, Howlader N, Krapcho M, et al. (eds). SEER Cancer Statistics Review, 1975 – 2015, National Cancer Institute, Bethesda, MD, http://seer.cancer.gov/csr/1975_2015/, based on November 2017 SEER data submission, posted to the SEER website April 2018.
  8. Screening includes methods with United States Preventative Services Task Force (USPSTF) A, B, or C rating (breast, colon, cervical, prostate, and lung).

© Providence and ISB, 2022. All rights reserved.